PROTEOGENIX
Live / Applied — Response to non-final action entered (as of 20 Mar 2026)
What this means for you
Not registered yet, but its 26 Aug 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79406602
- Mark type
- Stylized text
- Filed
- 26 Aug 2024
- Attorney of record
- Richard A. Castellano
Goods and services
- Class 005 — Pharmaceuticals: Biological and chemical products, chemical reagents, biological reagents, cell culture media, fermentation media, cell culture additives, recombinant proteins, monoclonal or polyclonal antibodies, non-medical detection and analysis kits, enzymes, buffers, lysis solutions, transfection agents, plasmids, synthetic or natural nucleic acids (DNA, RNA) for scientific, industrial or research use, synthetic peptides, products for peptide or genetic synthesis, expression vectors, cell lines, screening and selection products, reagents for PCR, qPCR, RT-PCR, NGS, proteomics, transcriptomics or genomics, analytical standards, isotopic or fluorescent labeling compounds, substances for the development of in vitro diagnostic tests, scientific consumables containing biological reagents, reagents for bioproduction, reagents for protein engineering, reagents for post-translational modifications, reagents for the development of vaccines or immunotherapies, raw materials for the manufacturing of biological drugs or diagnostic products for research use, and all chemical and biological products intended for biomedical research in life sciences, biotechnology, human and animal health, pharmacology, and diagnostics.
- Class 010 — Medical apparatus: Laboratory apparatus and instruments for use in biotechnology, molecular biology, immunology and diagnostic research; scientific diagnostic instruments for detecting DNA, proteins, antibodies, and other biomolecules, for research use only; in vitro laboratory equipment for scientific purposes, namely devices for analyzing biological samples in research laboratories.
- Class 042 — Scientific and technological services: Scientific and technological research in the fields of molecular biology, immunology, biotechnology, and diagnostics; biomedical research laboratory services; custom gene synthesis and peptide synthesis services; protein and antibody production and engineering; antibody humanization, maturation and optimization services; epitope and paratope mapping, antibody discovery services, Phage display, single B-cell screening, hybridoma development.
Owner
Prosecution history
- 26 Mar 2026 — NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
- 20 Mar 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 20 Mar 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 20 Mar 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 09 Mar 2026 — NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
- 09 Mar 2026 — NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
- 05 Mar 2026 — NOTIFICATION OF NOTICE OF UNRESPONSIVE AMENDMENT - E-MAILED
- 05 Mar 2026 — NOTICE OF UNRESPONSIVE AMENDMENT - E-MAILED
- 05 Mar 2026 — REPORT UNRESPONSIVE AMENDMENT - COMPLETED
- 08 Nov 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 07 Nov 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 07 Nov 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 05 Sept 2025 — REFUSAL PROCESSED BY IB
- 15 Aug 2025 — NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
- 14 Aug 2025 — REFUSAL PROCESSED BY MPU